Do Changes in Drug Coverage Policy Point to an Increased Role for Cost-Effectiveness Analysis in the USA?
Crossref DOI link: https://doi.org/10.1007/s40273-014-0166-6
Published Online: 2014-05-24
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chambers, James D.
Text and Data Mining valid from 2014-05-24